Nilufer Aesthetics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.20 M
as on 03-12-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.38 M
as on 03-12-2024
- Revenue 3.60%
(FY 2022)
- Profit -47.27%
(FY 2022)
- Ebitda -6.68%
(FY 2022)
- Net Worth 27.66%
(FY 2022)
- Total Assets 39.00%
(FY 2022)
About Nilufer Aesthetics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹4.38 M.
Fathima Sheriff and Nimi Mohamed serve as directors at the Company.
- CIN/LLPIN
U74993KL2018PTC052775
- Company No.
052775
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nilufer Aesthetics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Fathima Sheriff  | Director | 25-Jan-2021 | Current |
| Nimi Mohamed | Director | 29-Aug-2022 | Current |
Financial Performance of Nilufer Aesthetics.
Nilufer Aesthetics Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.6% increase. The company also saw a substantial fall in profitability, with a 47.27% decrease in profit. The company's net worth Soared by an impressive increase of 27.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nilufer Aesthetics?
Unlock access to Nilufer Aesthetics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Niro Aesthetics Private LimitedActive 3 years 9 months
Fathima Sheriff and Nimi Mohamed are mutual person
- Rayn Skin Clinic Private LimitedActive 11 years 1 month
Fathima Sheriff and Nimi Mohamed are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Nov 2022 | ₹4.38 M | Open |
How Many Employees Work at Nilufer Aesthetics?
Nilufer Aesthetics has a workforce of 4 employees as of Oct 15, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nilufer Aesthetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nilufer Aesthetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
